Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine

Infection and Immunity

Volumn 62, Issue 9, 1994, Pages 3972-3979

  Pier, G B ^a   DesJardin, D ^a   Grout, M ^a   Garner, C ^a   Bennett, S E ^a   Pekoe, G ^a   Fuller, S A ^a   Thornton, M O ^a   Harkonen, W S ^a   Miller, H C ^a  

^a CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; PSEUDOMONAS VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CYSTIC FIBROSIS; FEMALE; GLYCOSAMINOGLYCANS; HUMAN; MALE; POLYSACCHARIDES, BACTERIAL; PSEUDOMONAS AERUGINOSA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VACCINATION;

EID: 0028129061     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)